Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dixanthogen
- Development stage
- Discontinued
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Dixanthogen is an organosulfur compound belonging to the class of organic disulfides, with the chemical formula C6H10O2S4. It is a thiocarbonyl compound and functions as an ectoparasiticide, historically used topically for the treatment of scabies and other ectoparasitic infections[2][3][4][7]. Its mechanism of action involves acting as a parasite inhibitor, though detailed molecular targets are not well characterized. Dixanthogens are also formed by oxidation of xanthates and play a role in mineral flotation processes in industry[5][6][8]. The drug is no longer widely available for medical use.
- Brand names
- HerbisanSulfasan
- Other names
- AuligenBexidebisethylxanthogendiethyl dithiobis(thionoformate)diexanthogenethyl xanthogen disulfideO,O-diethyl dithiobis(thioformate)O,O-diethyl dithiobisthioformate
Beyond the preview
Go deeper on dixanthogen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dixanthogen.